MedPath

Exela Pharma Sciences, LLC

Exela Pharma Sciences, LLC logo
🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Efficacy and Safety of Tranexamic Acid in Spinal Fusion Surgery

Phase 3
Terminated
Conditions
Spinal Fusion
Interventions
Drug: Sodium Chloride 0.9% Inj
First Posted Date
2018-02-08
Last Posted Date
2021-06-21
Lead Sponsor
Exela Pharma Sciences, LLC.
Target Recruit Count
5
Registration Number
NCT03425799
Locations
🇺🇸

Spine Care Orthopedics - NYU Lagone Medical Center, New York, New York, United States

🇺🇸

Memorial Orthopaedic Surgery Group, Long Beach, California, United States

🇺🇸

Cedars-Sinai Medical Center, Los Angeles, California, United States

and more 1 locations

Comparative Efficacy and Safety of Ciprofloxacin 0.3% and Dexamethasone 0.1% in Acute Otitis Externa

First Posted Date
2014-08-13
Last Posted Date
2021-05-28
Lead Sponsor
Exela Pharma Sciences, LLC.
Target Recruit Count
499
Registration Number
NCT02216071
Locations
🇺🇸

Southland Clinical Reseach Center, Bellflower, California, United States

🇵🇷

Advance Medical Concepts, PSC, Cidra, Puerto Rico

🇺🇸

Birmingham Pediatric Associates, Birmingham, Alabama, United States

and more 42 locations
© Copyright 2025. All Rights Reserved by MedPath